: "fremanezumab for the preventive treatment of chronic migraine.".
.
.
plemmons and co-authors disclosed no relevant relationships with industry...
.
the news highlighted another factor in the chinese threat: regardless of the different regulatory framework, many researchers think the data they report is valid..
customize your news feed by choosing the topics that interest you..